| P50 | author | Tarik Regad | Q55474203 |
| | Luigi Mele | Q85886047 |
| P2093 | author name string | Angela Lombardi | |
| | Gianpaolo Papaccio | |
| | Federica Papaccio | |
| | Francesca Paino | |
| | Marcella La Noce | |
| | Vincenzo Desiderio | |
| | Virginia Tirino | |
| P2860 | cites work | Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo. | Q39579276 |
| | Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells | Q39932297 |
| | Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma | Q39978912 |
| | Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis | Q40213999 |
| | The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation | Q40690782 |
| | MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1. | Q41856145 |
| | CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance | Q42014961 |
| | Methylation of histone H3 K4 mediates association of the Isw1p ATPase with chromatin | Q44668068 |
| | Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study Group | Q45842022 |
| | Expression profiles of osteosarcoma that can predict response to chemotherapy. | Q46706109 |
| | Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development. | Q47104412 |
| | The fundamental role of epigenetic events in cancer | Q56421597 |
| | Long non-coding RNA SNHG20 promotes the tumorigenesis of oral squamous cell carcinoma via targeting miR-197/LIN28 axis | Q58610759 |
| | Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex | Q24324026 |
| | Massive genomic rearrangement acquired in a single catastrophic event during cancer development | Q24631164 |
| | Worms gang up on bacteria | Q27860588 |
| | A bivalent chromatin structure marks key developmental genes in embryonic stem cells | Q27860977 |
| | Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia | Q28202279 |
| | The epigenomics of cancer | Q28289975 |
| | CD271+ osteosarcoma cells display stem-like properties | Q28539288 |
| | Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription | Q29547568 |
| | Chromatin signatures of pluripotent cell lines | Q29614675 |
| | Epigenetics in cancer | Q29617139 |
| | The epigenetic progenitor origin of human cancer | Q29617486 |
| | Detection and characterization of CD133+ cancer stem cells in human solid tumours | Q33378520 |
| | Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer | Q34188991 |
| | Osteosarcoma treatment - where do we stand? A state of the art review. | Q34392457 |
| | Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization | Q34424921 |
| | Stem-like cells in bone sarcomas: implications for tumorigenesis | Q34769927 |
| | The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2 | Q35160462 |
| | Advances in sarcoma genomics and new therapeutic targets | Q35993346 |
| | Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways | Q36313178 |
| | Genetic and epigenetic regulators of pluripotency | Q36744480 |
| | Activation-induced cytidine deaminase (AID) is necessary for the epithelial-mesenchymal transition in mammary epithelial cells. | Q37088708 |
| | Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail | Q37114711 |
| | Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. | Q37235523 |
| | Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors | Q37347838 |
| | Epigenetics in cancer stem cells | Q37618640 |
| | Human adipose stem cell differentiation is highly affected by cancer cells both in vitro and in vivo: implication for autologous fat grafting. | Q37744842 |
| | A meta-analysis of osteosarcoma outcomes in the modern medical era | Q38006949 |
| | Epigenetic alterations involved in cancer stem cell reprogramming | Q38058972 |
| | EMT transcription factors: implication in osteosarcoma | Q38131450 |
| | Bone microenvironment signals in osteosarcoma development | Q38454980 |
| | The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines. | Q38543511 |
| | A common framework for EMT and collective cell migration. | Q39023896 |
| | Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma | Q39246205 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 296 | |
| P577 | publication date | 2018-12-03 | |
| P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
| P1476 | title | HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy | |
| P478 | volume | 37 | |